Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-11 02:37:10 EDT

Explore

PostsPeople
LatestRanked
@sigtrans-sttt.bsky.socialOct 6, 2026, 12:50 PM

How do gasdermin proteins execute inflammatory #CellDeath and drive disease pathology?

Insights into their activation, membrane pore formation, cell-death crosstalk, and context-dependent roles in #Inflammation, infection, and #Cancer.

#STTT #OpenAccess: doi.org/10.1038/s413...

The gasdermin family: from pyroptosis mechanisms to therapeutic targets
@sigtrans-sttt.bsky.socialOct 6, 2026, 9:30 AM

What drives #VascularCalcification beyond mineral deposition?
This review explores VSMC remodeling, #EndMT, cellular stress, and RUNX2-centered signaling crosstalk while assessing emerging therapeutic strategies.

#STTT #OpenAccess: doi.org/10.1038/s413...

Vascular calcification: pathogenic mechanisms, signaling crosstalk and translational therapeutics
@sigtrans-sttt.bsky.socialOct 6, 2026, 5:47 AM

Can hyperactive #DNArepair be targeted in #Neuroendocrine #CervicalCarcinoma?

#Multiomics reveals HRR activation and a CAF–IL6–E2F1–BLM axis that limits #PARP inhibitor sensitivity, supporting dual PARP–BLM inhibition.

#STTT #OpenAccess: doi.org/10.1038/s413...

Multi-omics profiling reveals homologous recombination repair hyperactivation as a therapeutic vulnerability in neuroendocrine cervical carcinoma
@sigtrans-sttt.bsky.socialOct 5, 2026, 3:45 PM

Loss of βPIX in alveolar type 2 cells impairs stemness through reduced Wnt/β-catenin signaling, promoting transitional senescent progenitors and #Myofibroblast activation that drive spontaneous #PulmonaryFibrosis.

#STTT #OpenAccess: doi.org/10.1038/s413...
#CancerAntigens

Alveolar epithelial depletion of βPAK-interacting exchange factor drives spontaneous pulmonary fibrosis by impairing stemness
@sigtrans-sttt.bsky.socialOct 5, 2026, 1:15 PM

A safer VSV-based intranasal #H5N1 #Vaccine elicits robust and durable humoral and mucosal immunity, with the optimized vector protecting against lethal viral challenge and supporting its potential for #AvianInfluenza prevention.

#STTT #OpenAccess: doi.org/10.1038/s413...
#CancerAntigens

Highly efficient intranasal H5N1 vaccine based on a safe vesicular stomatitis virus (VSV) vector
@sigtrans-sttt.bsky.socialOct 5, 2026, 9:14 AM

The melanoma-enriched noncanonical antigen EVA003 is endogenously presented on HLA-A*03:01 and recognized by a naturally occurring T cell receptor that, when transferred into T cells, enables antigen-dependent #Melanoma cell killing.

#STTT #OpenAccess: doi.org/10.1038/s413...

Receptor-defined targeting of a genomically unique melanoma-enriched noncanonical antigen
@sigtrans-sttt.bsky.socialOct 5, 2026, 5:56 AM

How durable is immunity after an XBB.1.5 booster? This longitudinal study tracks neutralizing antibody responses after trivalent XBB.1.5 #Vaccination, examining their magnitude, breadth, durability, and evolution against #SARSCoV2 variants.
#STTT #OpenAccess: doi.org/10.1038/s413...
#ImmuneEvasion

Dynamics of neutralizing antibody responses after trivalent XBB.1.5 booster vaccination: a 480-day longitudinal study
@sigtrans-sttt.bsky.socialOct 4, 2026, 3:30 PM

#CARTCellTherapy is moving beyond #Cancer.

This review explores its potential across #Autoimmune, aging-related, and #InfectiousDiseases, focusing on targeted cell depletion, immune remodeling, clinical advances, and translational challenges.

#STTT #OpenAccess: doi.org/10.1038/s413...

Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases
@sigtrans-sttt.bsky.socialOct 4, 2026, 12:30 PM

How do signaling networks guide #CellDifferentiation in health and disease?
This review explores Wnt, Notch, Hedgehog, TGF-β, and Hippo pathways, their regulatory crosstalk, disease roles, and potential for targeted therapies.
#STTT #OpenAccess: doi.org/10.1038/s413...

@sigtrans-sttt.bsky.socialOct 4, 2026, 6:30 AM

Researchers uncover an HPGDS–PGD2 pathway that promotes pathogenic Th17 differentiation by antagonizing PPARγ, while HPGDS inhibition suppresses Th17 responses and alleviates #Autoimmune pathology in #MultipleSclerosis models.

#STTT #OpenAccess: doi.org/10.1038/s413...
#DiseaseDetection

Targeting the HPGDS-PGD2 axis to treat Th17 cell-mediated autoimmunity in multiple sclerosis
@sigtrans-sttt.bsky.socialOct 4, 2026, 2:30 AM

A phase I trial evaluates CNSI-Fe, a carbon #Nanoparticle–Fe(II) complex that delivers Fe iron directly into tumors to trigger #Cancer cell #Ferroptosis, showing a favorable safety profile and preliminary antitumor activity.

#STTT #OpenAccess: doi.org/10.1038/s413...

Carbon nanoparticle-Fe (II) complex for ferroptosis therapy in refractory solid tumors: a phase I trial
@sigtrans-sttt.bsky.socialOct 3, 2026, 4:30 PM

Modulating #BACE1 transcription offers a different route to targeting #Amyloid pathology. Chlorhexidine suppresses BACE1 via a SOCS3-dependent JAK/STAT response, reducing amyloid pathology and cognitive deficits in AD models.

#STTT #OpenAccess: doi.org/10.1038/s413...
#CellTherapy

Transcriptional modulation of β-Secretase ameliorates amyloid pathology and cognitive deficits in Alzheimer’s disease models
@sigtrans-sttt.bsky.socialOct 3, 2026, 12:30 PM

Can gingiva-derived MSCs (GMSCs) help preserve β-cell function in #Type1Diabetes (#T1DM)? A phase 1 trial links GMSC therapy to improved residual β-cell function, potentially through CD8+ T-cell exhaustion.

#STTT #OpenAccess: doi.org/10.1038/s413...
#CellTherapy #BetaCellFunction

Safety and efficacy of human gingiva-derived mesenchymal stem cells in patients with type 1 diabetes: a double-blind, randomized, placebo-controlled, phase 1 trial
@sigtrans-sttt.bsky.socialOct 3, 2026, 6:30 AM

Infection and hypoxic stress converge on the PHD1–TRIM21–CDC20 axis, promoting CDC20 degradation and securin and MCL1 accumulation to drive cancer cell #Aneuploidy and #Chemoresistance.
#STTT #OpenAccess: doi.org/10.1038/s413...

Infection and α-ketoglutarate/oxygen inhibition converge to CDC20 to promote cancer cell aneuploidy
@sigtrans-sttt.bsky.socialOct 3, 2026, 3:00 AM

CDK12/13 inhibition exposes a vulnerability in platinum-resistant #OvarianCancer by disrupting transcription and #AlternativeSplicing, with the CDK12–SFPQ/p54nrb complex driving RNA-processing reprogramming and cytotoxicity.

#STTT #OpenAccess: doi.org/10.1038/s413...

CDK12/13 inhibition overcomes platinum resistance by impairing RNA metabolism
@sigtrans-sttt.bsky.socialOct 2, 2026, 3:30 PM

Muscle cells retain intrinsic #miRNA alterations in #Type2Diabetes. T2D-derived myoblasts show altered miRNA expression and sEV secretion linked to metabolic pathways, while their sEVs fail to enhance adipocyte metabolic function. @harvardmed.bsky.social

#STTT #OpenAccess: doi.org/10.1038/s413...

miRNAs as cell-intrinsic epigenetic regulators in muscle in type 2 diabetes
@sigtrans-sttt.bsky.socialOct 2, 2026, 12:30 PM

Mycobacterium abscessus directly links the #TumorMicrobiome to #NSCLC mutagenesis, as bacterial NDK phosphorylates IRF3 to amplify interferon signaling and sustain #APOBEC3A-driven genomic diversification.
#STTT #OpenAccess: doi.org/10.1038/s413...

Intratumoral Mycobacterium abscessus promotes cytidine deaminase mutagenesis in non-small cell lung cancer
@sigtrans-sttt.bsky.socialOct 2, 2026, 6:00 AM

The phase 3 ANCHOR trial finds that anlotinib + CapeOX shows similar antitumor activity to bevacizumab + CapeOX in RAS/BRAF wild-type #Metastatic #ColorectalCancer, but does not meet the prespecified noninferiority margin for PFS.

#STTT #OpenAccess: doi.org/10.1038/s413...

First-line anlotinib versus bevacizumab plus CapeOX in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ANCHOR): a multicenter, prospective, randomized, phase 3 trial
@sigtrans-sttt.bsky.socialOct 2, 2026, 2:30 AM

The phase 3 ICWIP #ClinicalTrial shows that three-year adjuvant icotinib following #Chemotherapy significantly improves disease-free survival versus placebo in completely resected stage II–IIIA disease, with a manageable safety profile.

#STTT #OpenAccess: doi.org/10.1038/s413...

Three-year adjuvant treatment of icotinib in stage II-IIIA EGFR-mutated lung adenocarcinoma (ICWIP): a randomized, double-blind, placebo-controlled phase 3 trial
@sigtrans-sttt.bsky.socialOct 1, 2026, 3:45 PM

miR-150 fine-tunes stem cell fate through dual control of #SOX2, regulating its mRNA stability and #Autophagy-mediated degradation via the KLHL20–ULK1 axis to balance ectodermal and mesodermal lineage commitment.
#STTT #OpenAccess: doi.org/10.1038/s413...

Dual-mode SOX2 regulation by miR-150 via mRNA suppression and autophagy controls stem cell fate
Load more